Metropolis Healthcare stock has broken out of a 17-week, 22% deep Consolidation Base 4-weeks ago. However, the stock is still offering investors an opportunity to get on board as the current price is only 5% away from the ideal buy price of INR 2323.
The key trend lines, 10 and 40-week moving averages are at a comfortable position. The current trends of both the averages are upward and the 10-week moving average is trending above the 40-week moving average. The current price of the stock is trading around 12.1% away from the 10-week moving average.
In the last twelve months, Metropolis Healthcare has rallied nearly 93.3% as compared to 51.1% for the Nifty500. It has a Relative Strength Rating of 64. We definitely would like to see improvement in the rating. At this point we are taking a step back and focusing on the RS Line.
The Relative Strength Line of the stock is offering making good progress in the recent weeks. If Metropolis Healthcare can maintain a healthy upward move, it could make sense as a CANSLIM trade.
Metropolis Healthcare stock has a strong institutional support. The Accumulation/Distribution Rating of ‘A+’ represents heavy institutional buying over the past 13 weeks. Although the number of institutions holding the stock dropped in the last quarter, the number of shares held by the institutions increased at the same time.
On the earnings front, Metropolis Healthcare has an excellent EPS Rank of 89, which indicates consistency in earnings. The sales for the stock have grown by 13% over the past three years; however the earnings growth remained muted at -7%. Its 3-years earnings stability is 31, on a 0 to 99 scale (lower the better). Over the past five years, the earnings and sales for the stock have grown by 13% and 15%, respectively. The 5-years earnings stability is 31. The return on equity for the last reported year is 24%.
The stock belongs to the industry group of Medical-Services. You would still want to see some improvement in the industry group rank for the group. The current industry group rank is 85. The current price of Metropolis Healthcare is -6% off from its 52-week high price and 107% above its 52-week low price.
The stock appears on our idea lists: Trend Template – 5 Months.